Noah E. Canvasser, M.D

Noah E. Canvasser, M.D.

Philosophy of Care Thorough communication is critical to determine optimal, individualized management strategies for each patient. I work to ensure that every patient fully understands his or her medical condition before embarking on various treatments. In addition, treatment decisions must be taken in the context of each patient's medical, social, and family environment. As such, I balance each patient's condition within their respective situation.

Clinical Interests Dr. Canvasser is a fellowship-trained endourologist and minimally invasive surgeon offering care for adults with kidney stone disease, kidney obstruction, kidney cancer, and enlarged prostates. He has a special interest in the medical management and prevention of patients with recurrent kidney stones. His surgical expertise includes complex percutaneous and ureteroscopic management of kidney stones, laparoscopic nephrectomy for kidney cancer and non-functioning kidneys, and robotic surgery, including partial nephrectomy for kidney cancer, pyeloplasty for ureteropelvic junction (UPJ) obstruction, reconstruction for kidney obstruction, and simple prostatectomy for enlarged prostates.

Research/Academic Interests Dr. Canvasser's research focuses on the prevention and management of patients with complex kidney stone disease, as well as improving minimally-invasive surgical management of kidney obstruction, kidney cancer, and enlarged prostates.

Title Assistant Professor, Department of Urology

Specialty Endourology, Minimally Invasive Surgery, Urology, Surgery - Robotic, Robotic Surgery

Department Urologic Surgery

Division Urology

Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

Additional Phone Clinic Fax: 916-734-7676 Physician Referrals: 800-4-UCDAVIS (800-482-3284) Education M.D., UC Irvine College of Medicine, Irvine CA 2010 B.S., UCLA, Los Angeles CA 2005 Internships General Surgery, University of Michigan Medical Center, Ann Arbor MI 2010-2011

Residency Urology, University of Michigan Medical Center, Ann Arbor MI 2011-2015

Noah E. Canvasser, M.D.

Fellowships Minimally Invasive Surgery and Endourology, University of Texas Southwestern, Dallas TX 2015- 2017 Board Certifications American Board of Urology

Professional Memberships American Urological Association Endourological Society Select Recent Publications Sorokin I, Canvasser NE, Irwin B, Autorino R, Liatsikos EN, Cadeddu JA, Rane A. The Decline of Laparoendoscopic Single-Site Surgery: A Survey of the Endourological Society to Identify Shortcomings and Guidance for Future Directions. J Endourol. 2017 Aug 28.

Canvasser NE, De S, Koseoglu E, Lay AH, Sorokin I, Fernandez R, Cadeddu JA. Three-Dimensional Printing of Surgical Clips: An In Vitro Pilot Study and Trial of Efficacy. J Endourol. 2017 Sep;31 (9):930-933.

Sorokin I, Canvasser NE, Margulis V, Lotan Y, Raj G, Sagalowsky A, Gahan JC, Cadeddu JA. Axial Abdominal Imaging after Partial Nephrectomy for T1 Renal Cell Carcinoma Surveillance. J Urol. 2017 Apr 23. pii: S0022-5347(17)57747-2.

Canvasser NE, Kay FU, Xi Y, Pinho DF, Costa D, de Leon AD, Khatri G, Leyendecker JR, Yokoo T, Lay A, Kavoussi N, Koseoglu E, Cadeddu JA, Pedrosa I. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Identify Clear Cell Renal Cell Carcinoma in cT1a Renal Masses. J Urol. 2017 Oct;198(4):780-786.

Kavoussi N, Canvasser N, Caddedu J. Ablative Therapies for the Treatment of Small Renal Masses: a Review of Different Modalities and Outcomes. Curr Urol Rep. 2016 Aug;17(8):59.

Canvasser NE, Alken P, Lipkin M, Nakada SY, Sodha HS, Tepeler A, Lotan Y. The economics of stone disease. World J Urol. 2017 Jan 20.

Noah E. Canvasser, M.D.

Canvasser NE, Sorokin I, Lay AH, Morgan MS, Ozayar A, Trimmer C, Cadeddu JA. Irreversible electroporation of small renal masses: suboptimal oncologic efficacy in an early series. World J Urol. 2017 Mar 2.

Canvasser NE, Lay AH, Koseoglu E, Morgan MS, Cadeddu JA. Posterior Urethral Suspension During Robot-Assisted Radical Prostatectomy Improves Early Urinary Control: A Prospective Cohort Study. J Endourol. 2016 Oct;30(10):1089-1094.

Canvasser NE, Stouder K, Lay AH, Gahan JC, Lotan Y, Margulis V, Raj GV, Sagalowsky AI, Cadeddu JA. The Usefulness of Chest X-Rays for T1a Renal Cell Carcinoma Surveillance. J Urol. 2016 Aug;196(2):321-6.

Lay AH, Stewart J, Canvasser NE, Cadeddu JA, Gahan JC. Likelihood of Incomplete Kidney Tumor Ablation with Radio Frequency Energy: Degree of Enhancement Matters. J Urol. 2016 Jul;196(1): 41-5.

Raul I. Clavijo, M.D.

Philosophy of Care For the patients I see in my clinic I strive to provide an educational setting where the patient is able to learn about his condition after which treatment options are presented. I feel a shared decision regarding treatment based on a patient's newly acquired understanding on his condition is essential to provide long term compliance and efficacy of a treatment plan. It is clear to me that this requires an individual approach as I have learned that not all patients will fit into established care algorithms.

Clinical Interests Dr. Clavijo is a urologist fellowship trained in andrology, including male reproductive medicine and surgery. He has a special interest in male reproductive tract reconstruction and treating conditions such as testosterone deficiency, varicocele, sexual dysfunction, infertility, erectile dysfunction (including the placement of penile implants) and Peyronie's disease. He is unique in the Sacramento area as he places a high volume of penile implants. He is skilled in microsurgery and performs vasectomy reversals (vasovasostomy/vasoepididymostomy), microdissection testicular sperm extraction (micro TESE), microsurgical epididymal sperm aspiration (MESA), testicular sperm aspiration (TESA) and microsurgical varicocelectomy.

Research/Academic Interests Dr. Clavijo's research focuses on the effects of lifestyle factors on sexual dysfunction, erectile dysfunction and male infertility. He also has an interest in novel therapies for erectile dysfunction such as low intensity shockwave therapy.

Title Assistant Professor, Department of Urologic Surgery

Specialty Male Reproductive Medicine and Surgery, Andrology, Urology

Department Urologic Surgery

Division Urology

Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

Additional Phone Clinic Fax: 916-734-7676 Physician Referrals: 800-4-UCDAVIS (800-482-3284) Email [email protected]

Languages Spanish

Raul I. Clavijo, M.D.

Education M.D., UC San Francisco School of Medicine, San Francisco CA 2010 B.A., UC Berkeley, Berkeley CA 2004 Internships General Surgery, UCLA, Los Angeles CA 2010-2011

Residency Urology, UCLA, Los Angeles CA 2011-2016

Fellowships Male Reproductive Medicine/Andrology, University of Miami, Miami FL 2016-2017

Board Certifications American Board of Urology DEA License, 2012 Professional Memberships American Urological Association International Society for Sexual Medicine Sexual Medicine Society of North America Honors and Awards Howard Hughes Medical Institute- Medical Research Training Fellowship, 2008 UCSF Medical Student Research Training Program Fellowship, 2006 Select Recent Publications Clavijo RI, Arora H, Gibbs E, Cohen S, Griswold A, Bakircioglu E, Bademci G, Tekin M, Ramasamy R. Whole Exome Sequencing of a Consanguineous Turkish Family Identifies a Mutation in GTF2H3 in Brothers with Spermatogenic Failure. Urology, 2018.

Hsiao P, Clavijo RI. Adverse Effects Of Cannabis On Male Reproduction. Euro Urol Focus, 2018

Waler NJ*, Clavijo RI*, Brackett NL, Lynne CM, Ramasamy R. Policy on Posthumous Sperm Retrieval: Survey of 75 Major Academic Medical Centers. 2018. Urology, 113: 45-51.

Lopategui DM, Griswold AJ, Arora H, Clavijo RI, Tekin M, Ramasamy R. A rare ANOS1 variant in siblings with Kallmann syndrome identified by whole exome sequencing. 2018. Andrology, 6(1): 53-57.

Clavijo RI, Hsiao W. Update on male reproductive endocrinology. 2018.Transl Androl Urol, 7 (Suppl 3): S367-S372.

Raul I. Clavijo, M.D.

Sávio LF, Prakash NS, Clavijo R, Kryvenko ON, Ramasamy R. Microsurgical identification and excision of an intratesticular mass. Fertil Steril. 2017 Apr;107(4):e16. Epub 2017 Feb 24.

Clavijo RI, Kohn TP, Kohn JR, Ramasamy R. Effects of Low-Intensity Extracorporeal Shockwave Therapy on Erectile Dysfunction: A Systematic Review and Meta-Analysis. J Sex Med. 2017 Jan;14 (1):27-35. Epub 2016 Dec 13.

Clavijo RI, Ramasamy R. Testosterone Replacement Should be Given to Men with Erectile Dysfunction: Pro. J Urol. 2017 Feb;197(2):284. Epub 2016 Dec 18.

Clavijo RI, Ramasamy R. Varicocele in a Young Man: Something We Should Be Worried About? Eur Urol. 2016 Dec;70(6):1030-1031. Epub 2016 Jul 29.

Clavijo RI, Daskivich T, Kwan L, Bassett J, Keller T, Bennett C. Patterns and Predictors of Use of Erectile Dysfunction Treatment in a Veterans Affairs Medical Center. Int J of Imp Res. 2016 May 19.

Kohn TP, Clavijo R, Ramasamy R, Hakky T, Candrashekar A, Lamb DJ, Lipshultz LI. Reproductive outcomes in men with karyotype abnormalities: Case report and review of the literature. Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E667-70. Epub 2015 Sep 9.

Clavijo RI, Miner MM, Rajfer J. Erectile Dysfunction and Essential Hypertension: The Same Aging- related Disorder? Rev Urol. 2014;16(4):167-71.

Raul I. Clavijo, M.D.

Smith JF, Shindel AW, Huang YC, Clavijo RI, Flechner L, Breyer BN, Eisenberg ML, Lue TF. Pentoxifylline treatment and penile calcifications in men with Peyronie's disease. Asian J Androl. 2011 Mar;13(2):322-5. Epub 2010 Nov 22.

Clavijo RI, Rose-Nussbaumer J, Turek PJ. Clinically symptomatic vasitis: clinical correlations in a rare condition. Syst Biol Reprod Med. 2010 Dec;56(6):445-9. Epub 2010 Oct 22.

Marc A. Dall'Era, M.D.

Clinical Interests Dr. Dall’Era specializes in the management of malignant disease of the urinary tract. The specialty care Dr. Dall’Era offers includes:

• Multi-disciplinary and comprehensive care of patients with urologic malignancy • Active surveillance for low risk prostate cancer • Multi-parametric MRI/US fusion targeted prostate biopsy • Blue Light Fluorescent cystoscopy for bladder cancer with Cysview • Minimally invasive and robotic surgery of the kidney and prostate including prostatectomy, partial nephrectomy, pyeloplasty/ureteral reconstruction • Radical cystectomy and neobladder creation • Advanced genomics testing of urologic cancers

Research/Academic Interests Dr. Dall'Era's research interests include active surveillance for prostate cancer including utilization of mp-MRI and biomarker discovery and validation. He is also involved in translational research for urothelial cancer diagnosis and management including advanced genomics analysis of bladder tumors.

Title Vice Chair, Department of Urologic Surgery Professor Specialty Cancer, Urologic Oncology, Urology, Robotic Surgery, Surgery - Robotic

Department Urologic Surgery

Division Urology

Center/Program Affiliation UC Davis Comprehensive Cancer Center

Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

UC Davis Comprehensive Cancer Center, 2279 45th Street Sacramento, CA 95817 Phone: 916-734-5959

Additional Phone Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Marc A. Dall'Era, M.D.

Education M.D., UC Davis, Davis CA 2000 B.S., UC Davis, Davis CA 1995 Internships General Surgery, University of Washington, Seattle WA 2000-2001

Residency Urology, University of Washington, Seattle WA 2001-2005

Fellowships Oncology, UC San Francisco, San Francisco CA 2006-2008

Board Certifications American Board of Urology

Professional Memberships American Association of Clinical Urologists American Urological Association Data and Safety Monitoring Board for the Prostate, Board Member Genitourinary (GU) Cancers Symposium News Planning Society of Urologic Oncology (SUO), Committee Member - Prostate Cancer Committee Society of Urologic Oncology (SUO), Spring Scientific Program Co-Chair Western Section American Urological Association, Board of Directors Select Recent Publications To view a detailed list of Dr. Dall'Era's publications, please click here.

Dall'Era, MA, Klotz, L. Active surveillance for intermediate-risk prostate cancer. Prostate Cancer and Prostatic Diseases. 2017;20(1):1-6.

Yap, SA, Yuh, LM, Evans, CP, Dall'Era, MA, Wagenaar, RM, Cress, R, Lara, PN. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry. World Journal of Urology. 2017;35(2):277-283.

Pugashetti, N, Chandrasekar,T, Lurvey, R, Durbin-Johnson, B, Dall'Era, M, de Vere White, R, Evans, C, Yap, S. Perioperative Outcomes Following Neoadjuvant Chemotherapy and Radical Cystectomy-Is There Room for Improvement? Urology Practice Journal. 2016;3:364-370.

Pan, A, Zhang, H, Li, Y, Lin, T, Wang, F, Lee, J, Cheng, M, Dall'Era, M, Li, T, de Vere White, R,

Marc A. Dall'Era, M.D.

Pan, C, Lam, K. Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer. Nanotechnology. 2016;27(42): 1-9.

Chandrasekar, T, Pugashetti, N, Durbin-Johnson, B, Dall'Era, MA, Evans, CP, de Vere White, RW, Yap, SA. Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact? Bladder cancer (Amsterdam, Netherlands). 2016;2(4): 441-448.

Chow, H, Ghosh, PM, de Vere White, R, Evans, CP, Dall'Era, MA, Yap, SA, Li, Y, Beckett, LA, Lara, PN, Pan, CX. A phase 2 clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer. Cancer. 2016;122(12):1897-904.

Marc A. Dall'Era, Benjamin J. Davies. Clinical Case Discussion: Intermediate-Risk Prostate Cancer: The Case for Active Surveillance. European Urology Focus. 2015;1(2):208-209.

Dall’Era MA, Maddala T, Polychronopoulos L, Gallagher JR, Febbo PG, Denes BS. Utility of the Oncotype DX Prostate Cancer Assay in Clinical Practice for Treatment Selection in Men Newly Diagnosed with Prostate Cancer: A retrospective Chart Review Analysis. Urology Practice. 2015;2: 343-348.

Yuh L, Dall’Era MA, Penson DF, Evan CP. Active Surveillance for Prostate Cancer Under the Patient Protection and Affordable Act. Urology Practice. 2015;2(4):154-159.

Pugashetti N, Yap SA, Lara PN, Gandour-Edwards R, Dall’Era MA. Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour. Canadian Urological Association Journal. 2015;9(3-4):E204-207.

Ralph W. de Vere White, M.D.

Research/Academic Interests Dr. de Vere White is the Senior Advisor Emeritus, and Emeritus Distinguished professor of urology. Prior to retiring, he served as the associate dean for cancer programs at UC Davis School of Medicine, director of the UC Davis Comprehensive Cancer Center and was a distinguished professor of urology. He received his medical degree from Dublin University in Dublin, Ireland, and completed an internship and residencies in surgery and urology at St. Vincent’s Hospital in Dublin and at Duke University Medical Center in Durham, NC. The author of more than 300 peer-reviewed scientific articles and book chapters, Dr. de Vere White has served on the editorial boards of six international scientific journals. Post-retirement, his research efforts are now focused on the molecular events that govern the response of prostate and bladder cancer to targeted therapies, the biomolecular mechanisms that make some prostate cancers more virulent than others, and new methods of diagnosing and treating prostate cancer. He is the past president-elect of the Society of Urologic Oncology, a member of the Clinical Society of Genitourinary Surgeons and an elected member of the prestigious American Association of Genitourinary Surgeons. He has been named multiple times as one of "The Best Doctors in America" and is one of four urologists serving as a volunteer consultant to the American Cancer Society's on-line "Experts Answers" bulletin board for questions about prostate cancer.

Title Senior Advisor Emeritus Emeritus Distinguished Professor of Urology Specialty Cancer, Urologic Oncology, Urology

Department Office of the Dean, School of Medicine Urologic Surgery Division Urology

Center/Program Affiliation UC Davis Comprehensive Cancer Center

Address/Phone UC Davis Comprehensive Cancer Center, 4501 X St. Suite 3003 Sacramento, CA 95817 Phone: 800-362-5566

Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

Education M.B., B.Ch., B.A.O., Dublin University, Dublin, Ireland, 1970

Residency Duke University Medical Center, Durham NC 1974-1977 St. Vincents Hospital, Dublin, Ireland, 1970-1974

Ralph W. de Vere White, M.D.

Board Certifications American Board of Urology, 1979

Professional Memberships American Academy of Clinical Urologists American Association of Anatomists American Association of Genitourinary Surgeons American Cancer Society American Fertility Society American Medical Association American Urological Association Northern California Oncology Group Northern California Urological Society Past President, Society of Urologic Oncology Honors and Awards Huggins Award for Lifetime Achievement, 2013 Komen Promise Award, 2012 Healthcare Hero, Sacramento Business Journal, 2012 Elected to Best Doctors in America, Best Doctors Inc., 2012 UC Davis School of Medicine Research Award, 2011 UCDMG Most Distinguished Graduate Award, Dublin Ireland, 2006 Listed in 2005-2006 "The Best Doctors in America" national reference directory (Woodward White Inc., publishers), 2005 Excellence in Mentoring Prize, UC Davis School of Medicine, 2004 "Spirit Project," State of California Lieutenant Governor, Cruz M Bustamante, 2003 Strathmores Whos Who Lifetime Member Award, 2003 Select Recent Publications Amir S, Ma A-H, Shi X-B, Xue L, Kung H-J, et al. (2013) Oncomir miR-125b Suppresses p14ARF to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer. PLoS ONE 8(4): e61064. doi:10.1371/journal.pone.0061064

Liu C, Zhu Y, Lou W, Nadiminty N, Chen X, Zhou Q, Shi XB, deVere White RW, Gao AC. Functional p53 determines docetaxel sensitivity in prostate cancer cells. Prostate 73(4):418-427. (2013)

Jung C, Iyengar S, Blahnik K, Jiang J, Tahimic C,Torok N, deVere White RW, Farnham P and Zern M. Human ESC self-renewal promoting miRNAs induce epithelial-mesenchymal transplant hepatocytes by controlling the PTEN and TTGB tumor suppressor signaling pathway. Molecular Cancer Research, 10(7):979-991. (2012)

Ralph W. de Vere White, M.D.

Lin TY, Li YP, Zhang H, Luo J, Goodwin N, Gao T, deVere White RW, Lam KS, Pan CX. Tumor- targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer. Nanomedicine (Long). 2012 Dec 2 [Epub ahead of print].

Shi, XB, Xue L, Ma, A-H, Tepper CG, Gandour-Edwards R, Kung H-J, deVere White RW. Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene, Oct 15. doi: 10.1038/onc.2012.425

Mooso BA, Vinall RL, Tepper CG, Savoy RM, Cheung JP, Singh S, Siddiqui S, Wang Y, Bedolla RG, Mudryj M, deVere White RW and Ghosh PM. Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization. Endocr Relat Cancer. 19(6):759-777. (2012)

Vinall RL, Kent MS, deVere White RW. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma. Am J Vet Res. 2012 Oct:73(10):1626-33.

Nadiminity N, Tummala R, Lou W, Zhu Y, Shi XB, Zou JX, Chen HW, Zhang J, Chen X, Luo J, deVere White RW, Kung HJ, Evans CP, Gao AC.“MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth. PLoS One. 7(3)e32832. Epub 2012 Mar 30.

Sarachine MJ, Buchholz BA and deVere White RW. Stem-like cells in bladder cancer cell lines with differential sensitivity to cisplatin. Anticancer Research 32:733-738.

Vinall RL, Chen JQ, Hubbard NE, Suaimon SS, deVere White RW, and Borowsky AD. Initiation of prostate cancer in mice by Tp53R270: an alternative molecular progression. Disease Models % 26amp%3B Mechanisms, 2012 May 31. [Epub ahead of print]

Ralph W. de Vere White, M.D.

Jacobson MC, deVere White RW and Demos SG. In vivo testing of a prototype system providing simultaneous white light and near infrared autofluorescence image acquisition for detection of bladder cancer. Journal of Biomedical Optics, 17(3). (2012)

Berglund RK, Tangen CM, Powell IS, Lowe BA, Haas GP, Carroll PR, Canby-Hagino ED, deVere White RW, Hemstreet GP, Crawford ED, Thompson IM and Klein EA. Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: Update on Southwest Oncology Group Study 9109. Urology 79(3) 633-637. (2012)

Lin TY, Zhang H, Luo J, Li Y, Gao T, Lara PN, deVere White RW, Lam KS and Pan C-X. Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. Inter J of Nanomed, 2012:7 1-12.

Vinall RL, Ripoll AZ, Wang S, Pan CX and Devere White RW. MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status. Int J Cancer, 130(11): 2526-2538, 2012.

Christopher P. Evans, M.D.

Philosophy of Care Dr. Evans' philosophy of care is to:

• fully assess the patient's medical condition, including how it relates to family and social circumstances; • educate the patient fully about their disease process; and • include the patient in the decision-making process that best suits the outcomes they seek. In each case he looks for opportunity to enroll them in any new therapies or clinical trials that may be available and pertinent.

Clinical Interests Dr. Evans' practice is dedicated to the management of patients with urologic malignancies. He works with medical oncologists and radiation oncologists to provide multimodal approaches to cancer therapy. His surgical expertise includes robotic assisted laparoscopic radical prostatectomy with nerve sparing, complex renal surgery to include partial nephrectomy and vena cava thrombectomy, cystectomy with extended pelvic lymph node dissection and urinary diversion with orthotopic neobladders. Dr. Evans also has expertise in treating patients with metastatic testicular cancer and performing retroperitoneal lymph node dissection in post chemotherapy patients.

Research/Academic Interests Dr. Evans is the president of the Society of Urologic Oncology. His research laboratory focuses on prostate cancer; specifically, mechanisms signaling the androgen receptor to activate prostate cancer growth and progression following castration. His laboratory has developed models to study this and has identified novel mechanisms that activate the androgen receptor. His laboratory work has also tested new agents and brought them from bench studies to animal models to clinical trials.

Title Professor

Specialty Cancer, Urologic Oncology, Urology, Robotic Surgery, Surgery - Robotic

Department Urologic Surgery

Division Urology

Clinic Urology Clinic

Center/Program Affiliation Robotic Surgery Program

Christopher P. Evans, M.D.

UC Davis Comprehensive Cancer Center

Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

UC Davis Comprehensive Cancer Center, 2279 45th Street Sacramento, CA 95817 Phone: 916-734-5959

Additional Phone Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Languages German

Education M.D., F.A.C.S., Dartmouth Medical School, Hanover NH 1986 B.A., University of Vermont, Burlington VT 1981 Internships Madigan Army Medical Center, Tacoma WA 1986-1987

Residency Surgery, UC San Francisco, San Francisco CA 1990-1991 Urology, UC San Francisco, San Francisco CA 1991-1995 Fellowships University of California, San Francisco National Kidney Foundation Research Fellow, San Francisco CA 1993-1994 Urologic Oncology, University of Texas, M.D. Anderson Cancer Center, Houston TX 1995-1997 Board Certifications American Board of Urology, 2009 American College of Surgeons, 2000 National Board of Medical Examiners, 1987 Professional Memberships American Association for Cancer Research American Association for the Advancement of Science American Association of Genitourinary Surgeons American College of Surgeons American Society of Clinical Oncology, Past Chair, Genitourinary Cancer American Urology Association Association of Military Surgeons of the United States European Association of Urology Society for Basic Urologic Research Society of Government Urologists Southwest Oncology Group Uniformed Services University

Christopher P. Evans, M.D.

Honors and Awards Recipient, The Platinum Award, European Association of Urology (EAU), 2018 American Association of Genitourinary Surgeons, Elected Membership, 2009 Western Section AUA nominee for the Gold Cystoscope Award, 2005 1st Prize, Joseph F. McCarthy Essay Contest of the American Urological Association, 2003 Finalist, California Cancer Research Program Gerald P. Murphy Award, 2001 Honorable Mention, AUA Circon/ACMI Essay Contest, Laboratory Research, 1996 First Place Award for Basic Science, Society for University Urology Residents, National Chief Resident Meeting, 1995 Recipient, American Association for Cancer Research Young Investigator Award, Basic and Clinical Aspects of Prostate Cancer, 1994 Recipient, American Association for Cancer Research/National Cancer Institute Travel Grant, Molecular Biology, Aspen, CO, 1993 Recipient, Army Commendation Medal, 1990 Finalist, Army Science Conference Competition, 1990 Select Recent Publications To view a detailed list of Dr. Evans' publications, please click here.

Evans, CP. Bipolar Androgen Therapy: An Intriguing Paradox. Lancet Oncology. 19(1):8-10.

Wang, HJ, Pochampalli, M, Wang, LY, Zou, JX, Li, PS, Hsu, SC, Wang, BJ, Huang, SH, Yang, P, Yang, JC, Chu, CY, Hsieh, CL, Sung, SY, Li, CF, Tepper, CG, Ann, DK, Gao, AC, Evans, CP, Izumiya, Y, Chuu, CP, Wang, WC, Chen, HW, Kung, HJ. KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC. Oncogene.

Messing, EM, Tangen, CM, Lerner, SP, Sahasrabudhe, DM, Koppie, TM, Wood, DP, Mack, PC, Svatek, RS, Evans, CP, Hafez, KS, Culkin, DJ, Brand, TC, Karsh, LI, Holzbeierlein, JM, Wilson, SS, Wu, G, Plets, M, Vogelzang, NJ, Thompson, IM. Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial. JAMA. 2018;319(18): 1880-1888.

Quigley, DA, Dang, HX, Zhao, SG, Lloyd, P, Aggarwal, R, Alumkal, JJ, Foye, A, Kothari, V, Perry,

Christopher P. Evans, M.D.

MD, Bailey, AM, Playdle, D, Barnard, TJ, Zhang, L, Zhang, J, Youngren, JF, Cieslik, MP, Parolia, A, Beer, TM, Thomas, G, Chi, KN, Gleave, M, Lack, NA, Zoubeidi, A, Reiter, RE, Rettig, MB, Witte, O, Ryan, CJ, Fong, L, Kim, W, Friedlander, T, Chou, J, Li, H, Das, R, Li, H, Moussavi-Baygi, R, Goodarzi, H, Gilbert, LA, Lara, PN, Evans, CP, Goldstein, TC, Stuart, JM, Tomlins, SA, Spratt, DE, Cheetham, RK, Cheng, DT, Farh, K, Gehring, JS, Hakenberg, J, Liao, A, Febbo, PG, Shon, J, Sickler, B, Batzoglou, S, Knudsen, KE, He, HH, Huang, J, Wyatt, AW, Dehm, SM, Ashworth, A, Chinnaiyan, AM, Maher, CA, Small, EJ, Feng, FY. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. Cell. 174(3):758-769.e9.

Nguyen, HG, Conn, CS, Kye, Y, Xue, L, Forester, CM, Cowan, JE, Hsieh, AC, Cunningham, JT, Truillet, C, Tameire, F, Evans, MJ, Evans, CP, Yang, JC, Hann, B, Koumenis, C, Walter, P, Carroll, PR, Ruggero, D. Development of a stress response therapy targeting aggressive prostate cancer. Sci Transl Med. 2018;10(439).

Tilki D, Chandrasekar T, Capitanio U, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Espinos EL, Lorentz A, Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat S, Spahn M, Terrone C, Vera-Donoso C, Zigeuner R, Libertino JA, Evans CP. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: results from the International Renal Cell Carcinoma- Venous Thrombus Consortium (IRCC-VTC). Urologic Oncology-Seminars and Original Investigations. 36(2):79.e11-79.e17.

Wyatt AW, Annala M, Aggarwal R, Beja K, Feng F, Youngren J, Foye A, Lloyd P, Nykter M, Beer TM, Alumkal JJ, Thomas GV, Reiter RE, Rettig MB, Evans CP, Gao AC, Chi KN, Small EJ, Gleave ME. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer. Journal of the National Cancer Institute. 2017 Jun 29;109(12). https://doi.org/10. 1093/jnci/djx118.

Evans CP, Higano CS, Keane T, Andriole G, Saad F, Iversen P, Miller K, Kim CS, Kimura G, Armstrong AJ, Sternberg CN, Loriot Y, de Bono J, Noonberg SB, Mansbach H, Bhattacharya S,

Christopher P. Evans, M.D.

Perabo F, Beer TM, Tombal B. The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration- resistant Prostate Cancer. Eur Urol. 2016 Oct:70(4):675-683.

Wang J, Zou JX, Xue X, Cai D, Zhang Y, Duan Z, Xiang Q, Yang JC, Louie MC, Borowsky AD, Gao AC, Evans CP, Lam KS, Xu J, Kung HJ, Evans RM, Xu Y, Chen HW. ROR- drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nat Med. 2016 May 22;22(5):488-96.

Chandrasekar T, Yang JC, Gao AC, Evans CP. Targeting molecular resistance in castration-resistant prostate cancer. BMC Med. 2015 Sep 1;13:206. doi: 10.1186/s12916-015-0457-6. Review.

Allen Gao, M.D., Ph.D.

Research/Academic Interests Dr. Gao’s research interests focus on understanding molecular mechanisms associated with progression of castration-resistant prostate cancer and metastasis to bone with the goal of identification of potential therapeutic targets for prostate cancer. Particular emphasis includes microRNAs, aberrant androgen receptor activation by cytokines and transcriptional factors such as Stat3 and NF-kB, targeting cell signaling pathways (AR, IL-6 and Stat3), and mechanisms of drug resistance in prostate cancer. Dr. Gao’s lab was among the first to find that selenium regulates androgen signaling and that IL-4 activates the androgen receptor mediated by NF-B and Stat6, made the discovery that IL-6 signaling in prostate cancer involves Stat3, defined Stat3 and NF-B interactions in prostate cancer, discovered niclosamide as a novel inhibitor of androgen receptor variants (AR-V7), and identified several novel resistance mechanisms to enzalutamide/abiraterone/docetaxel including p52, IL- 6/Stat3, intracrine androgens/AKR1C3, and ABCB1. Dr. Gao has published over 100 peer-reviewed articles in the area of prostate cancer. His research findings such as the discovery of niclosamide as a novel inhibitor of androgen receptor variants have translated into several clinical trials (NCT02807805, NCT03123978) that test the combination treatments with current therapies to advanced resistant prostate cancer. Another recent discovery of indomethacin as an inhibitor of AKR1C3 and synergizing enzalutamide has also translated into clinical trial (NCT02935205) to test the combination treatments with current therapies to advanced resistant prostate cancer. Dr. Gao has served numerous NIH, NCI, DOD and VA merits, and American Cancer Society (ACS) review panels including SPORE and PPG study sections.

Title Professor Ralph de Vere White Professor and Director of Urologic Research Co-Leader, Prostate Cancer Program Specialty Cancer, Urologic Oncology, Urology

Department Urologic Surgery

Division Urology

Clinic Urology Clinic

Center/Program Affiliation UC Davis Comprehensive Cancer Center

Address/Phone Research III, Research Building III, 4645 Second Ave Sacramento, CA 95817

Allen Gao, M.D., Ph.D.

Additional Phone Phone: 916-734-8718 Fax: 916-734-8714 Education M.D., Sichuan Medical College, Chengdu, Sichuan, 1985 Ph.D., MD Anderson Cancer Center, University of Texas, Houston, 1995 Fellowships John Hopkins University School of Medicine, Baltimore, Maryland, 1998

Professional Memberships 2018-2019 President, Society of Basic Urologic Research American Association for Cancer Research American Society of Clinical Oncology American Urological Association Editorial Board, The Prostate, American J. of Pathology European Urological Association Society of Basic Urologic Research Honors and Awards Ralph deVere White Endowed Professor of Urologic Research, University of California, Davis, 2008 Research Career Scientist, VA Northern California Health Care System, Sacramento, CA, 2015 Select Recent Publications Lombard AP, Liu L, Cucchiara V, Liu C, Armstrong CM, Zhao R, Yang JC, Lou W, Evans CP, Gao AC. Intra versus inter cross-resistance determines treatment sequence between taxane and AR- targeting therapies in advanced prostate cancer. Mol Cancer Ther. 17(10):2197-2205, 2018.

Liu C, Lou W, Yang JC, Liu L, Armstrong CM, Lombard AP, Zhao R, Noel ODV, Tepper CG, Chen HW, Dall'Era M, Evans CP, Gao AC. Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer. Nat Commun. 9(1):4700, 2018.

Liu C, Lou W, Zhu Y, Yang JC, Nadiminty N, Gaikwad NW, Evans CP, Gao AC. Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer. Can Res. 75(7):1413-22, 2015.

Lombard AP, Liu C, Armstrong CM, Cucchiara V, Gu X, Lou W, Evans CP, Gao AC. ABCB1 mediates cabazitxel-docetaxel cross-resistance in advanced prostate cancer. Mol Cancer Ther. 16 (10):2257-2266, 2017.

Allen Gao, M.D., Ph.D.

Liu C, Armstrong C, Lou W, Lombard A, Evans CP, and Gao AC. Inhibition of AKR1C3 activation overcomes resistance to abiraterone in advanced prostate cancer. Mol Cancer Ther. 16(1):35-44, 2017.

Nadiminty N, Tummala R, Liu C, Lou W, Evans CP, Gao AC. NF-kB/p52:c-myc:hnRNPA1 pathway regulates expression of androgen receptor splice variants and enzalutamide sensitivity in prostate cancer. Mol Cancer Ther. 14:1884-95, 2015.

Zhu Y, Liu C, Armstrong C, Lou W, Sandher A, Gao AC. Antiandrogens inhibit ABCB1 efflux and ATPase activity and reverse docetaxel resistance in advanced prostate cancer. Clin Can Res. 21: 4133-42, 2015.

Liu C, Lou W, Zhu Y, Nadiminty N, Schwartz C, Evans CP, Gao AC. Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration resistant prostate cancer. Clin Can Res. 20:3198-210, 2014.

Zhu YZ, Liu, C.F., Nadiminty, N., Lou, W., Tummala, R., Evans, C.P., Gao, A. C. Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer. Mol Cancer Ther 2013 12 (9): 1829-36.

Nadiminty N, Tummala R, Lou W, Zhu YZ, Evans CP, Gao AC. NF-kB2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants. Molecular Cancer Ther 2013 12 (8): 1629-37.

Allen Gao, M.D., Ph.D.

Paramita M. Ghosh, M.Sc., Ph.D.

Research/Academic Interests My current research concentrates on the study of signal transduction pathways involved in prostate cancer development and progression. This includes studies on the EGFR family of receptor tyrosine kinases, leading to the PI3K/Akt pathway and finally to the mTOR signaling pathway. In particular, I investigate the interaction of these pathways with the androgen receptor. My research involves identification of significant therapeutic targets, as well as studying the effects of inhibitors of those targets both in vitro as well as in animal models. I am currently funded to study drug combinations that target parallel signaling pathways and in combination, appear to be highly effective in inhibiting the progression of prostate cancer.

Title Professor

Specialty Cancer, Urologic Oncology, Urology

Department Urologic Surgery Biological Chemistry and Molecular Medicine Division Urology

Center/Program Affiliation UC Davis Comprehensive Cancer Center

Address/Phone Oak Park Research Center Building, 2700 Stockton Blvd. Room 1132 Sacramento, CA 95817 Phone: 916-734-7805

Additional Phone Clinic Fax: 916-734-8904 Clinic Referral Phone: 916-734-7805 Physician Referrals: 800-4-UCDAVIS (800-482-3284) Languages Bengali

Education B.Sc., Jadavpur University, Calcutta, India 1986 M.Sc., Jadavpur University, Calcutta, India 1988 Ph.D., Rensselaer Polytechnic Institute, Troy NY 1994 B.Sc., Jadavpur University, Calcutta, India 1986 Ph.D., Renesselaer Polytechnic Institute, Troy NY 1994 Fellowships Pathology, University of Texas Health Science Center, San Antonio TX 1994-2000

Professional Memberships American Association for Cancer Research American Association for the Advancement of Science American Urological Association

Paramita M. Ghosh, M.Sc., Ph.D.

The Society for Basic Urologic Research

Select Recent Publications Shih TC, Liu R, Wu CT, Li X, Xiao W, Deng X, Kiss Z, Wang T, Chen X, Carney RP, Kung HJ, Duan Y, Ghosh PM, Lam KS. Targeting Galectin-1 impairs castration-resistant prostate cancer progression and invasion. Clin Cancer Res. 24(17):4319-4331. 2018.

D'Abronzo LS, Ghosh PM. eIF4E Phosphorylation in Prostate Cancer. Neoplasia. 20(6):563-573.

D'Abronzo LS, Pan CX, Ghosh PM. Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum. Methods Mol Biol. 1655:319-334. 2018.

Kent MS, Zwingenberger A, Westropp JL, Barrett LE, Durbin-Johnson BP, Ghosh P, Vinall RL. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples. BMC Vet Res. 13(1):339. 2017.

D'Abronzo LS, Bose S, Crapuchettes ME, Beggs RE, Vinall RL, Tepper CG, Siddiqui S, Mudryj M, Melgoza FU, Durbin-Johnson BP, deVere White RW, Ghosh PM. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer. Oncogene. 36(46):6359-6373. 2017.

Shih TC, Liu R, Fung G, Bhardwaj G, Ghosh PM, Lam KS. A Novel Galectin-1 Inhibitor Discovered through One-Bead Two-Compound Library Potentiates the Antitumor Effects of Paclitaxel in vivo. Molecular cancer therapeutics. 16(7):1212-1223. 2017.

Kiss Z, Ghosh PM. Circadian rhythmicity and the influence of 'clock' genes on prostate cancer. Endocrine-related cancer. 2016 Nov;23(11):T123-T134.

Chow H, Ghosh PM, deVere White RW, Evans CP, Dall’Era MA, Yap SA, Li Y, Beckett LA, Lara PN,

Paramita M. Ghosh, M.Sc., Ph.D.

Pan CX. A Phase II clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer. Cancer. 2016 Jun 15;122(12):1897-904.

Pan, CX, Zhang, H, Tepper, CG, Lin, TY, Davis, RR, Keck, J, Ghosh, PM, Gill, P, Airhart, S, Bult, C, Gandara, DR, Liu, E, de Vere White, RW. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy. PloS one. 2016;10(8): e0134346.

Savoy, R.M., Chen, L., Siddiqui, S., Melgoza, F.U., Durbin-Johnson, B., Drake, C., Jathal, M.K., Bose, S., Steele, T.M., Mooso, B.A., D’Abronzo, L.S., Fry, W.H., Carraway, K.L. III, Mudryj, M. and Ghosh, P.M. Transcription of Nrdp1 by the androgen receptor is regulated by nuclear Filamin A in prostate cancer. Endocrine-related Cancer. 2015. Mar 10. pii: ERC-15-0021 (PMID: 25759396).

John E. Gould, M.D.

Philosophy of Care Wherever the art of medicine is loved, there is also love of humanity. Clinical/Research Interests John E. Gould specializes in male infertility including vasectomy reversal, microsurgical sperm extraction, electroejaculation, and vasopididymostomy.

Title Professor

Specialty Urology

Department Urologic Surgery

Division Urology

Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

Additional Phone Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Education M.D., Ph.D., UC Davis School of Medicine, Sacramento, California, 1984 B.A., Williams College, Williamstown, Massachusetts, 1974 Residency University of California, Davis Medical Center, Sacramento, California, 1984-89

Board Certifications American Board of Urology, 2009

Professional Memberships Alpha Omega Alpha American Society for Reproductive Medicine American Urological Association, Inc. Society for Male Reproduction and Urology Society for the Study of Male Reproduction Western Section American Urologic Association Select Recent Publications Greco, C.M., Soontrapornchai, K., Wirojanan, J., Gould, J., Hagerman, PJ., and Hagerman, RJ. Testicular and pituitary inclusion formation in fragile X-associated tremor/ataxia syndrome. J. Urology 177, April 2007, p. 1434-1437. Overstreet, l.W., Fuh, Y.L., Gould, l.E., Howards, S.S., Lieber, M.M., Hellstrom, W., Shapiro, S., Carroll, P., Corfman, R.S., Petrou, S., Lewis, R., Toth, P., Shown, T., Roy, J., Jarow, J.P., Bonilla, J., Jacobsen, C.A., Wang, D.Z. and Kaufman, K.D. Chronic treatment with finasteride daily does not

John E. Gould, M.D.

affect spermatogenesis or semen production in young men. J. Urology 162, October 1999, p. 1295-1300. Qui, Q., Kuo, A., Todd, H., Dias, J.A., Gould, J.E., Overstreet, J.W. and Lasley, B.L. Enzyme immunoassay method for total urinary follicle-stimulating hormone (FSH) beta subunit and its application for measurement of total urinary FSH. Fertility and Sterility, Vol 69 (2), February 1998, p. 278-285. Gould, J.E, Immunology of Spermatozoa. In William R. Keye, Jeffrey Chang, Robert W. Rabar and Michael R. Soules (Eds). Infertility: Evaluation and Treatment, 1995, 43:666-670. Gould, J.E. Brazil, C.K. and Overstreet, lW. Sperm-Immunobead Binding Decreases with in vitro Incubation. Fertility and Sterility, Vol 62 (1), July 1994, p. 167-171. Queralt, J.A., Gerscovich, E.O., Gould, lE. and Cronan, M.S. Intraoperative Trans rectal Ultrasonography in the Management of Ejaculatory Duct Obstruction Caused by Midline Prostatic Cyst. J. Clin. Ultrasound. 21:293-298, May 1993. Gould, J.E. Testicular Biopsy and Flow Cytometry. J.W. Overstreet (ed), Infertility and Reproductive Medicine Clinics of North America. April 1992, p. 373-387. Gould, J.E., Switters, D.M., Broderick, G.A. and deVere White, R.W. External vacuum devices: A clinical comparison with pharmacologic erections. World Journal of Urology 10:68-70,1992. Gould, J.E. Immunologic Infertility, L Wayne J.G. Hellstrom (Ed.) Male Infertility and Sexual Dysfunction, 1997, 128-142.

Eric A. Kurzrock, M.D., F.A.A.P.

Clinical Interests Eric A. Kurzrock's practice is dedicated to the urologic care of infants, children and adolescents. His areas of expertise include diagnosis and treatment of hypospadias, prenatal and congenital hydronephrosis, hernias, hydroceles, neurogenic bladder, sexual ambiguity, undescended testicles, urinary infection, and vesico-ureteral reflux. He has written extensively on pediatric urology and urogenital development. His research interests focus on reconstructive techniques, stem cell biology and tissue engineering.

Title Chief, Pediatric Urologic Surgery Professor, Department of Urologic Surgery and Pediatrics Specialty Pediatric Urology

Department Urologic Surgery

Division Pediatric Urologic Surgery

Center/Program Affiliation UC Davis Children's Hospital

Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

Additional Phone Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Languages Spanish

Education M.D., UCLA School of Medicine, Los Angeles CA 1991 B.A., UC Berkeley, Berkeley CA 1987 Internships University of Southern California, Los Angeles CA 1991-1993

Residency Pediatric Urology, University of Southern California, Los Angeles CA 1993-1997

Fellowships Pediatric Urology, University of California, San Francisco CA 1997-1999

Board Certifications American Board of Urology American Board of Urology, Pediatric Urology Professional Memberships American Association of Pediatric Urologists American Urological Association Fellow, American Academy of Pediatrics

Eric A. Kurzrock, M.D., F.A.A.P.

Fellow, Society for Pediatric Urology Society for Fetal Urology Urologic Research Society Honors and Awards U.S. News & World Report top-50 pediatric urology program, 2011-12 U.S. News & World Report top-50 pediatric urology program, 2012-13 U.S. News & World Report top-50 pediatric urology program, 2014-15 U.S. News & World Report top-50 pediatric urology program, 2015-16 U.S. News & World Report top-50 pediatric urology program, 2016-17 U.S. News & World Report top-50 pediatric urology program, 2017-18 U.S. News & World Report top-50 pediatric urology program, 2018-19 Select Recent Publications Kurzrock EA, Chan Y, Durbin-Johnson B, DeCristoforo L. Pictorial Urgency Scale - A New Tool for Evaluating Bladder Urgency in Children. Journal of Urology, In-Press, 2018.

Chan YY, Gonzalez R, Kurzrock EA. Malone antegrade continence enema: Is cecal imbrication essential? J of Pediatric Urology, In-Press, 2018.

Sturm R, Kurzrock EA, Amend G, Shannon R, Gong EM, Cheng EY. Blind-ending Vessels on Diagnostic Laparoscopy for Nonpalpable Testis: Is a Nubbin Present? J of Pediatric Urology. 2017; 13(4):392.

Chan YY, Sandlin SK, Kurzrock EA. Urological Outcomes of Myelomeningocele and Lipomeningocele. Curr Urol Rep. 2017;18(5):35.

Chan Y, Sturm R, Durbin-Johnson B, Kurzrock EA. Outcomes after Pediatric Open, Laparoscopic and Robotic Pyeloplasty at Academic Institutions. J of Pediatric Urology. 2017;13(1):49.

Chan YY, Sandlin SK, Kurzrock EA, Osborn SL. The Current Use of Stem Cells in Bladder Tissue Regeneration and Bioengineering. Biomedicines. 2017;5(1):4-8.

Eric A. Kurzrock, M.D., F.A.A.P.

Chan Y, Sturm R, Durbin-Johnson B, Kurzrock EA. Pediatric inguinal and scrotal surgery – practice patterns in U.S. academic centers. J Pediatric Surgery. 2016;51:786-90.

Cantrell A, Rothschild J, Durbin-Johnson B, Kurzrock EA. Surgical trends in the correction of female stress urinary incontinence in academic centers. Neurourology and Urodynamics. 2015;36 (2):394-398.

Lurvey R, Durbin-Johnson B, Kurzrock EA. Adolescent Varicocelectomy: Large Multicenter Analysis. J of Pediatric Urology. 2015;11:186.

Osborn SL, So M, Hambro S, Nolta J, Kurzrock EA. Inosculation of blood vessels allows early perfusion and vitality of bladder grafts - implications for bioengineered bladder wall. Tissue Engineering. 2015;21:1906-15.

Chengfei Liu, M.D., Ph.D.

Research/Academic Interests Dr. Liu has extensive expertise in clinical oncology and prostate cancer research. He has identified novel resistant mechanisms and developed innovative pharmaceutical approaches to treat advanced prostate cancer patients. He has also generated a number of unique tools that have allowed him to elucidate how resistance emerges in late stage prostate cancer. Dr. Liu's long-term research interest is to bridge the basic and clinical research that ultimately yields novel translational efforts in urologic oncology. His ideas and research will yield new paradigms for protein post translational modification and drug resistance in cancer cells, advance the understanding of cancer biology and provide opportunities for innovative cancer therapeutics. Dr. Liu's current research program focuses on understanding the mechanisms of therapy resistance and progression in lethal prostate cancer with specialized focus on drug development for the treatment of prostate cancer. Dr. Liu has interests in nuclear receptors, chaperone protein modification, ubiquitin proteasome regulation, steroid hormone biosynthesis and metabolism, clinical translational research and tumor immunology.

Title Assistant Professor

Specialty Prostate Cancer, Urologic Oncology, Urology

Department Urologic Surgery

Division Urology

Center/Program Affiliation UC Davis Comprehensive Cancer Center

Address/Phone UC Davis Medical Center, 2315 Stockton Blvd. Sacramento, CA 95817 Phone: 800-2-UCDAVIS (800-282-3284)

Additional Phone Phone: 916-734-5902 Physician Referrals: 800-4-UCDAVIS (800-482-3284) Languages Mandarin

Education M.D., Sichuan University, China 2005 Ph.D., Sichuan University, China 2012 Internships Oncology, West China Hospital, Sichuan University, Chengdu, China 2005-2006

Residency Oncology, West China Hospital, Sichuan University, Chengdu, China 2009-2010

Chengfei Liu, M.D., Ph.D.

Fellowships Urology/Urological Research, UC Davis, Sacramento CA 2012-2016

Professional Memberships American Association for Cancer Research (AACR) American Urological Association Society for Basic Urologic Research Honors and Awards NCI Method to Extend Research in Time (MERIT)(R37) Award, 2021 NCI Paul Calabresi Clinical Oncology K12 Career Development Award, 2020 UC Davis Academic Federation Travel Award, 2019 Best Poster Award in 2017 AUA (American Urological Association) meeting, Boston MA, 2017 Training Award, SBUR Symposium, "Omics in Urologic Research: New Frontiers Driving Precision Medicine", Dallas TX, 2014 Best Poster Award in 2011 AUA (American Urological Association) meeting, Washington DC, 2011 Select Recent Publications Zhao J, Shu N, Lou W, Zhu Y, Yang JC, Armstrong C, Evans CP, Gao AC, Liu C. Cross-resistance among next generation anti-androgen drugs through the AKR1C3/AR-V7 axis in advanced prostate cancer. Mol Cancer Ther. 2020 Aug;19(8):1708-1718. doi:10.1158/1535-7163.MCT-20-0015. Epub 2020 May 19. PMID:32430485.

Armstrong C, Liu C, Liu L, Yang JC, Lou W, Evans CP, Gao AC. Steroid sulfatase stimulates intracrine androgen synthesis and is a therapeutic target for advanced prostate cancer. Clin Cancer Res. 2020;26(22):6064-6074. PMID:32928794.

Liu C, Yang JC, Armstrong C, Lou W, Liu L, Qiu X, Zou B, Lombard AP, D'Abronzo LS, Evans CP, Gao AC. AKR1C3 promotes AR-V7 protein stabilization and confers resistance to AR-targeted therapies in advanced prostate cancer. Mol Cancer Ther. 2019;18(10):1875-1886. PMID: 31308078.

Liu C, Lou W, Yang JC, Liu L, Armstrong C, Lombard AP, Zhao R, Noel ODV, Tepper CG, Chen HW, Dall'Era M, Evans CP, Gao AC. Protein homeostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer. Nature Comm. 2018;16;9(1):4700. PMID:30446660.

Chengfei Liu, M.D., Ph.D.

Liu C, CM A, Lombard A, Evans CP, Gao AC. Inhibition of AKR1C3 activation overcomes resistance to abiraterone in advanced prostate cancer. Mol Cancer Ther. 2017;16(1):35-44. PMID: 27794047.

Liu C, Lou W, Zhu Y, Yang JC, Nadiminty N, Gaikwad NW, Evans CP, Gao AC. Intracrine androgens and AKR1C3 activation confer resistance to enzalutamide in prostate cancer. Cancer Research. 2015;75(7):1413-22. PMID:25649766.

Zhu Y, Liu C, Armstrong C, Lou W, Sandher A, Gao AC. Anti-androgens inhibit ABCB1 efflux and ATPase a ctivity and reverse docetaxel resistance in advanced prostate cancer. Clin Cancer Res. 2015;21(18):4133-42. PMID:25995342.

Liu C, Lou W, Zhu Y, Nadiminty N, Schwartz C, Evans, CP, Gao AC. Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration resistant prostate cancer. Clin Cancer Res. 2014;20 (12):3198-210. PMID:24740322.

Liu C, Zhu, Y, Lou, W, Cui, Y, Evans, CP, Gao AC. Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells. The Prostate. 2014;74:201-9. PMID:24307657.

Liu C, Zhu Y, Lou W, Nadiminty N, Chen X, Zhou Q, Shi XB, deVere White RW, Gao AC. Functional p53 determines docetaxel sensitivity in prostate cancer cells. The Prostate. 2013;73: 418-27. PMID:22996738.

Neasha McMeo, M.S.N., F.N.P.-B.C.

Philosophy of Care I value providing health education to patients and families, so that together we can create goals and make treatment decisions that are best for the patient.

Clinical Interests Neasha's clinical interests include implementing approved evidence based strategies that improve quality of life of patients with chronic urological conditions.

Title Nurse Practitioner

Specialty Urology, Pediatric Urology

Department Urologic Surgery

Division Urology

Clinic Urology Clinic

Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

Additional Phone Clinic Phone: 916-734-7520 Clinic Fax: 916-734-8769 Physician Referrals: 800-4-UCDAVIS (800-482-3284) Education M.S.N., State University of New York at Buffalo, Buffalo NY 2008 B.S.N., State University of New York at Buffalo, Buffalo NY 2006 B.A., State University of New York at Buffalo, Buffalo NY 2006 Board Certifications American Nurses Credentialing Center - Family Nurse Practitioner Nurse Practitioner (California), Family Nursing Nurse Practitioner (New York), Family Nursing Professional Memberships American Urological Association California Nurse Practitioner Association Psi Chi, the International Honor Society in Psychology Sigma Theta Tau International Honor Society of Nursing Society of Urologic Nurses and Associates Honors and Awards You Cared Recipient- Mt Sinai South Nassau (NY), 2016, 2017, 2018 Anne Walker Sengbush Award- University at Buffalo, 2008 Arthur A. Schomburg Fellowship Scholarship- University at Buffalo, 2006, 2007, 2008 Graduate Nurse Organization (GNO) Award for outstanding community service University at

Neasha McMeo, M.S.N., F.N.P.-B.C.

Buffalo, 2006

Jonathan Peter Moore, M.D.

Philosophy of Care I believe that patient education and understanding of their condition, therapeutic options, and treatment pathway are key to improved patient outcomes. I strive to work together with my patients to achieve a personalized approach to their Urological concerns that best addresses their problem.

Clinical Interests Dr. Moore is a Urologists with additional fellowship training in Endourology and minimally invasive surgery. He focuses on the comprehensive medical and surgical treatment of patients with recurrent kidney stones, acute kidney stone attacks, and enlarged prostates. Dr. Moore's surgical expertise includes standard and miniaturized percutaneous nephrolithotomy, advanced ureteroscopic management of kidney stones, as well as laparoscopic and robotic surgery for kidney cancer and kidney obstruction. He also specializes in the treatment of men with enlarged prostates and bladder outlet obstruction with a variety of techniques including Holmium Laser Enucleation of the Prostate (HoLEP).

Research/Academic Interests Dr. Moore's research focuses on the prevention of kidney stones and management of patients with complex or hereditary causes of kidney stone disease. He also has interest in the development, testing, and assessment of new surgical technology and their application to the surgical treatment of kidney stones, benign prostate hyperplasia (BPH), and robotic surgery.

Title Assistant Professor

Specialty Urology, Endourology

Department Urologic Surgery

Division Urology

Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

Additional Phone Clinic Fax: 916-734-7676 Physician Referrals: 800-4-UCDAVIS (800-482-3284) Education M.D., Dalhousie Medicine New Brunswick, Saint John, NB, Canada 2014 B.Sc., Dalhousie University, Halifax, NS, Canada 2010 Internships Urology, Dalhousie University, Halifax, NS, Canada 2014-2015

Residency Urology, Dalhousie University, Halifax, NS, Canada 2015-2019

Jonathan Peter Moore, M.D.

Fellowships Endourology and Minimally Invasive Surgery, Mayo Clinic Arizona, Phoenix AZ 2019-2021

Board Certifications American Board of Urology - board eligible Medical Board of California Royal College of Physicians and Surgeons of Canada - Urology Professional Memberships American Urological Association Canadian Urological Association Endourological Society Honors and Awards Western Section AUA Conference - Joseph F. McCarthy Physician Essay Contest - 2nd Place, 2021 Resident Teaching Award, Dalhousie University, Department of Urology, 2019 Select Recent Publications Moore J, Nevo A, Abdul-Muhsin H, Keddis M, Stern K, Humphreys M. Dissolution of Uric Acid Stones Quantification by Automated Computed Tomography Stone Volume. Accepted for publication J Nephrol. 2021 Jun.

Narang G, Shimon T, Moore J, Hager M, Pinto e Vairo F, Stern K, Keddis M, Humphreys M. Novel variant in CLDN16: A further step in the diagnosis of familial hypomagnesemia with hypercalciuria and nephrocalcinosis, a case report. Uro. 2021 Jun;1(3):76-81. doi:10.3390/uro1030011.

Ory J, White JT, Moore J, Grantmyre J. Canadian trends in testosterone therapy. Can Urol Assoc J. 2021 Jun;15(6):210-212. doi:10.5489/cuaj.6892. PMID:33212007.

Narang G, Moore J, Abdul-Muhsin H, Humphreys M, Cheney S. Holmium laser enucleation of the prostate: A description of the fundamental skills. Videourol. 2021 May;35(4). doi:10.1089/vid. 2020.0132.

Nevo A, Faraj KS, Cheney SM, Moore JP, Stern KL, Borofsky M, Gnessin E, Humphreys MR. Holmium laser enucleation of the prostate using Moses 2.0 vs non-Moses: a randomised controlled trial. BJU Int. 2021 May;127(5):553-559. doi:10.1111/bju.15265. Epub 2020 Nov 1. PMID: 33025749.

Jonathan Peter Moore, M.D.

Nevo A, Stern KL, Moore JP, Humphreys MR, Tyson MD, Keddis MT. The impact of phone counseling on urinary stone prevention. World J Urol. 2021 May;39(5):1625-1629. doi:10.1007 /s00345-020-03320-x. Epub 2020 Jun 25. PMID:32588206.

Nevo A, Moore JP, Humphreys MR, Salih S, Keddis MA, Rose KM, Cheney SS, Stern KL. Does bladder stone composition predict kidney stone composition? Can J Urol. 2020 Dec;27(6):10450- 10455. PMID:33325347.

Forbes CM, Lundeen C, Beebe S, Moore JP, Knudsen BE, Humphreys MR, Chew B. Device profile of the LithoVue single-use digital flexible ureteroscope in the removal of kidney stones: overview of safety and efficacy. Expert Rev Med Devices. 2020 Dec;17(12):1257-1264. doi:10.1080/17434440. 2020.1848538. Epub 2020 Dec 14. PMID:33307869.

Nevo A, Muchtar E, Stern KL, Moore JP, Cheney SM, Humphreys MR, Grogan M, Stanton ML. The Clinical Implication of Incidental Prostatic Amyloidosis. Urology. 2020 Nov;145:253-257. doi: 10.1016/j.urology.2020.08.053. Epub 2020 Sep 19. PMID:32961226.

Moore J, Whelan TF, Langille GM. The use of penile prostheses in the management of priapism. Transl Androl Urol. 2017 Nov;6(Suppl 5):S797-S803. doi:10.21037/tau.2017.04.26. PMID:29238659.

Dana Nanigian, M.D.

Specialty Urology

Department Urologic Surgery

Division Urology

Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

Additional Phone Clinic Fax: 916-734-7422 Physician Referrals: 800-4-UCDAVIS (800-482-3284) Education M.D., UC Davis, Davis CA 2002

Internships UC Davis Medical Center, Sacramento CA 2004

Residency UC Davis Medical Center, Sacramento CA 2008

Board Certifications American Board of Urology

Jennifer Rothschild, MD, M.A., M.P.H.

Philosophy of Care Dr. Rothschild’s philosophy of care is to educate her patients so they fully understand the breadth of their diagnosis and treatment plan. Dr. Rothschild believes in including patients in the decision making process with detailed discussions about the expectations they seek.

Clinical Interests Dr. Rothschild specializes in the diagnosis and treatment of male and female urinary incontinence. Her expertise includes lower urinary tract reconstruction, including neuromodulation and botox for over active bladder and urethral strictures, as well as complex genitourinary reconstructions including urinary fistula repair and transvaginal mesh complications. Dr. Rothschild is skilled in multichannel urodynamic evaluation. She is also skilled in prosthetic surgery, specializing in artificial urinary sphincters and penile prosthetics.

Research/Academic Interests Currently Dr. Rothschild is conducting research in outcomes in artificial urinary sphincters as well as sacral neuromodulation.

Title Assistant Professor

Specialty Urology, Female Pelvic Medicine and Reconstructive Surgery

Department Urologic Surgery

Division Urology

Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

Additional Phone Clinic Fax: 916-734-7676 Physician Referrals: 800-4-UCDAVIS (800-482-3284) Education M.D., Boston University School of Medicine, Boston MA 2005 M.P.H., Health Law, Boston University School of Medicine, Boston MA 2001 M.A., Medical Sciences, Boston University School of Medicine, Boston MA 2001 B.S., UC Santa Cruz, Santa Cruz CA 1997 Internships Surgery, University of Rochester School of Medicine and Dentistry, Rochester NY 2006

Residency Urologic Surgery, University of Rochester School of Medicine and Dentistry, Rochester NY 2011

Fellowships Female Medicine and Reconstructive Surgery, Vanderbilt University Medical Center, Nashville TN 2013 Board Certifications American Board of Urology

Jennifer Rothschild, MD, M.A., M.P.H.

Professional Memberships American Urologic Association Society of Genitourinary Reconstructive Surgeons Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction Society of Women in Urology Honors and Awards Best Poster Presentation Award, 2009 Boston University School of Medicine Summer Research Scholarship, 2002 Select Recent Publications Cantrell AB, Rothschild J, Durbin-Johnson B, Gonzalez R, Kurzrock EA. Surgical trends in the correction of female stress urinary incontinence in academic centers within the United States. Neurourol Urodyn. 2015 Dec 17. [Epub ahead of print]

Rothschild J, Chang Kit L, Seltz L, Wang L, Kaufman M, Dmochowski R, Milam DF. Difference between urethral circumference and artificial urinary sphincter cuff size, and its effect on postoperative incontinence. J Urol. 2014 Jan;191(1):138-42. Epub 2013 Jun 29.

Rothschild J, Thompson IM 3rd, Concepcion RS, Shore ND. Infusion therapy and implantables for the urologist. Urol Clin North Am. 2013 Nov;40(4):591-8. Review.

Osborn DJ, Strain M, Gomelsky A, Rothschild J, Dmochowski R. Obesity and female stress urinary incontinence. Urology. 2013 Oct;82(4):759-63. Epub 2013 Aug 22. Review.

Rothschild JG and Wu G: Ureteritis cystica: a radiologic pathologic correlation. Journal of Clinical Imaging Science. 2011;1:23–23.

Rothschild J, Bhatt S and Dogra VS: Renal collision tumor in association with xanthogranulomatous pyelonephritis. Journal of Clinical Imaging Science. 2011;1:9–9.

Rothschild J and Eichel L: Davinci robotic-assisted laparoscopic right upper pole heminephrectomy and ureterectomy in a duplicated renal collecting system. The Journal of Urology. 2010;183(4),

Jennifer Rothschild, MD, M.A., M.P.H.

Supplement 1, e373. AUA Annual Meeting Program Abstracts, AUA.

Rothschild JG and Dmochowski RR: Mesh for Stress Incontinence. Current Bladder Dysfunction Reports. 2012;7:210–214.

Roy S, Rothschild JG, and Chen A: Vascular complications and gene therapy. Expert Opinions in Biological Therapeutics. 2003;3(1):71-83.

Paula J. Wagner, R.N., F.N.P.-C, M.S.N

Philosophy of Care Paula Wagner is devoted to providing comprehensive, high-quality health care.

Clinical Interests Paula Wagner provides inpatient and outpatient care to patients and for children who have urological problems. She provides evaluation and diagnosis of patients with urological symptoms and urodynamics.

Specialty Urology

Department Urologic Surgery

Division Urology

Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

UC Davis Medical Group - Roseville, 1620 East Roseville Parkway Suite 200 Roseville, CA 95661 Phone: 916-783-7109

Additional Phone Clinic Fax: 916-734-7676 Physician Referrals: 800-4-UCDAVIS (800-482-3284) Education F.N.P.-C., American Academy of Nurse Practitioners Certification Board, 2002 M.S., Nursing, Sonoma State, 1999 N.P., California Board of Nursing, 2000 R.N., Nursing, Sacramento City College, 1993 B.S., Nursing, Sacramento State, 1997 Board Certifications American Academy of Nurse Practitioners

Professional Memberships American Academy of Nurse Practitioners California Coalition of Nurse Practitioners Society of Urological Nurses Honors and Awards Sigma Theta Tau International Honor Society of Nursing, 2000

Select Recent Publications Rogers JH, Goldstein I, Kandzari DE, Köhler TS, Stinis CT, Wagner PJ, Popma JJ, Jaff MR, Rocha- Singh KJ. Zotarolimus-Eluting Peripheral Stents for the Treatment of Erectile Dysfunction in Subjects with Suboptimal response to Phospjodiesterase-5 Inhibitors. Journal of the American College of Cardiology. 2012;60(25):2618-27.

Paula J. Wagner, R.N., F.N.P.-C, M.S.N

Wagner P. Teaching CIC to Children. Dialogues in Pediatric Urology. 2000;23(11).

Jennifer H. Yang, M.D.

Clinical Interests Dr. Yang specializes in providing urologic care for infants and children. Her practice involves the diagnosis and treatment of prenatal and congenital hydronephrosis, undescended testicles, hydroceles, hernias, neurogenic bladder, urinary infections and vesico-ureteral reflux. Dr. Yang's expertise also includes complex genitourinary reconstructions including hypospadias repair and management of disorders of sex development.

Title Assistant Professor Residency Program Director Specialty Pediatric Urology, Urology, Surgery - Robotic, Robotic Surgery

Department Urologic Surgery

Division Pediatric Urology

Center/Program Affiliation UC Davis Children's Hospital Robotic Surgery Program Address/Phone Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817 Phone: 916-734-2222

Additional Phone Clinic Fax: 916-734-7676 Physician Referrals: 800-4-UCDAVIS (800-482-3284) Languages Mandarin, Spanish

Education M.D., University of Texas Medical School at San Antonio, San Antonio TX 2002 B.A., University of Pennsylvania, Philadelphia PA 1998 B.S., University of Pennsylvania, Philadelphia PA 1998 Internships The New York Presbyterian Hospital/Weill Medical College of Cornell, New York NY 2004

Residency Urology, The New York Presbyterian Hospital/Weill Medical College of Cornell, New York NY 2008 Fellowships Pediatric Urology, UC San Francisco, San Francisco CA 2010

Board Certifications American Board of Urology American Board of Urology, Pediatric Urology Professional Memberships American Academy of Pediatrics Section on Urology

Jennifer H. Yang, M.D.

American Urological Association Society of Pediatric Urology Society of Women in Urology Western Section, American Urological Association Honors and Awards John Coleman Resident Teaching Award, 2007 Clinical Research Prize Finalist, American Academy of Pediatrics Society of Pediatric Urology, 2006 U.S. News World Report Top-50 Pediatric Urology Program, 2012, 2014, 2015 Select Recent Publications Yiee JH, Baskin LS, Patel N, Yang JH, Disandro M. Prospective Blinded Laboratory Assessment of Prophylactic Antibiotic Compliance in a Pediatric Outpatient Setting. Journal of Urology. 2012;187 (6):2176-81.

Blaschko SD, Yang JH, Baskin LS, Deng DY. Combined method of bladder neck closure and concomitant augmentation cystoplasty in the setting of refractory urinary incontinence. Urology. 2012 Apr;79(4):955-7. Epub 2012 Feb 18. Rodriguez E Jr, Weiss DA, Yang JH, Menshenina J, Ferretti M, Cunha TJ, Barcellos D, Chan LY, Risbridger G, Cunha GR, Baskin LS. New insights on the morphology of adult mouse penis. Biol Reprod. 2011 Dec;85(6):1216-21. Epub 2011 Sep 14. Yang JH, Menshenina J, Cunha GR, Place N, Baskin LS. Morphology of mouse external genitalia: implications for a role of estrogen in sexual dimorphism of the mouse genital tubercle. J Urol. 2010 Oct;184(4 Suppl):1604-9. Epub 2010 Aug 21.

Yang JH, Baskin LS, DiSandro M. Gender identity in disorders of sex development: review article. Urology. 2010;75(1):153-9.

Yang JH, Mitchell K, Poppas DP. Case report of granular cell tumor of the glans penis in a 9 year old male. Urology. 2008;71(3):546e1-2.

Yang JH, Poppas DP. Nerve sparing reduction clitoroplasty: analysis of clitoral sensitivity and viability. Journal of Urology. 2007;178(4 Pt 2):1598-601.

Jennifer H. Yang, M.D.

Yang JH, Donat SM. Elisabeth Pauline Pickett (1918-): Opening the door for women in urological oncology. Journal of Urology. 2007;178(5):1875-7.

Yang JH and Te AE. Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome. Current Urology Reports. 2005;6(4):290-5.

McGowan JC, Yang JH, Plotkin RC, Grossman RI, Umile EM, Cecil KM, Bagley LJ. Magnetization transfer imaging in the detection of injury associated with mild head trauma. American Journal of Neuroradiology. 2000;21(5):875-80.